Author : Mike Khan
Publisher :
ISBN 13 :
Total Pages : 188 pages
Book Rating : 4.:/5 (11 download)
Book Synopsis Unfolding the Intracellular Lifestyle of Brucella by : Mike Khan
Download or read book Unfolding the Intracellular Lifestyle of Brucella written by Mike Khan and published by . This book was released on 2017 with total page 188 pages. Available in PDF, EPUB and Kindle. Book excerpt: Brucella species are Gram-negative, intracellular pathogens which cause brucellosis, the most common zoonosis worldwide. Human brucellosis is a severely debilitating disease with a major socioeconomic impact. Brucellosis has eluded systematic attempts at eradication for more than a century in even the most developed countries. Currently, no human vaccine exists and vaccines used on animals present many difficulties. Brucella spp. invade many cell and tissue types including reproductive tissues, neurons, epithelial, and non-professional and professional phagocytes. The intracellular lifestyle of Brucella limits exposure to the host innate and adaptive immune responses and sequesters the organisms from the effects of antibiotics. The mechanisms by which Brucella subverts the host to enable chronic infection remain unclear. To better design future vaccines, further knowledge of these mechanisms is critical. The goal of this thesis was to elucidate mechanisms from both the host and the pathogen that contribute to the intracellular lifestyle of Brucella. In Chapter II, we describe how Brucella triggers the host Unfolded Protein Response, which supports its intracellular survival. In Chapter III, we describe the effects of the ubiquitous bacterial second messenger, cyclic-di-GMP, on Brucella virulence and host immune pathways. Finally, in Chapter IV, we describe the active evasion of innate immunity by Brucella through the up-regulation of microRNA 24. Taken together, these data identify novel host and bacterial mechanisms that contribute to the long-term survival of Brucella as well as provide novel targets for future vaccines and therapeutics.